After Gilead controversy, lawmakers seek details on HHS patent reviews STAT
A pair of lawmakers wants more information on how HHS manages patents and licenses for medicines discovered, at least in part, with taxpayer dollars.
After Gilead controversy, lawmakers seek details on HHS patent reviews STAT
A pair of lawmakers wants more information on how HHS manages patents and licenses for medicines discovered, at least in part, with taxpayer dollars.